The Native Antigen Company is part of LGC Clinical Diagnostics - Learn More

0 Items
Select Page

Rabbit Anti-Shigella Species Antibody

$300.99 excl. VAT

Protein G purified antibody isolated from a pool of serum from rabbits immunized with Shigella. This antibody is broadly reactive to Shigella species. Part of the BacTrace® range of antigens and antibodies.

RABBIT ANTI-SHIGELLA SPECIES ANTIBODY

Protein G purified antibody isolated from a pool of serum from rabbits immunized with Shigella. This antibody is broadly reactive to Shigella species.

 

PRODUCT DETAILS – RABBIT ANTI-SHIGELLA SPECIES ANTIBODY

  • Part of the BacTrace® range of antigens and antibodies.
  • Protein G purified antibody made in rabbit.
  • Isolated from a pool of serum from rabbits immunized with Shigella.
  • Tested by Elisa technique as applicable. This antibody is broadly reactive to Shigella species.
  • Product is in lyophilized form.
  • Each lot is tested to assure specificity and lot-to-lot consistency using an in-house ELISA assay.

 

BACKGROUND

Shigella is the primary agent of bacillary dysentery, also referred to as shigellosis. Shigellae are Gram-negative, non-motile rods that are transmitted by the direct faecal–oral route. There are four species within the genus Shigella: Shigella dysenteriae, Shigella flexneri, Shigella boydii, and Shigella sonnei. These four species are also designated as subgroups A, B, C, and D, respectively. With the exception of S. sonnei, each species is made up of multiple serovars. S. dysenteriae has 15 serovars, S. flexneri has six serovars (with one to five possessing subtypes a and b), and S. boydii has 20 serovars.

Shigella species cause an estimated 167 million episodes of diarrhea worldwide and over a million deaths. S. sonnei is predominantly responsible for dysentery in developed countries but is replacing S. flexneri as a problem in the developing world. Foodborne outbreaks are often linked to salad items contaminated at the country of origin or by the food handler. The global spread of Shigella clones or the emergence of new S. flexneri serotypes is associated with multidrug resistance. As the antibiotic-resistant Shigella strains are increasing worldwide, they severely limit treatment options (Aslam & Okafor, 2021).

 

REFERENCES

  • Aslam A, Okafor CN. Shigella. 2021 Aug 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 29493962.

Product Datasheet
Safety datasheet

Ambient